Darunavir
Back to searchMolecule Structure
Scientific Name
Darunavir
Description of the Drug
Darunavir is a HIV protease inhibitor used in the treatment of human immunodeficiency virus (HIV) infection in patients with history of prior antiretroviral therapies.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01264
http://www.drugbank.ca/drugs/DB01264
Brand Name(s)
Prezista
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Janssen Products Lp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 protease | SINGLE PROTEIN | INHIBITOR | CHEMBL243 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL118546 | |||
| PharmGKB | PA163522472 | |||
| Human Metabolome Database | HMDB0015393 | |||
| DrugBank | DB01264 | |||
| PubChem: Thomson Pharma | 14788134 | |||
| PubChem | 213039 | |||
| LINCS | LSM-45520 | |||
| Nikkaji | J2.037.394F | |||
| PDBe | 017 | |||
| BindingDB | 8125 | |||
| EPA CompTox Dashboard | DTXSID0046779 | |||
| DrugCentral | 4143 | |||
| Brenda | 23670 | 164284 | 164283 | 1901 |
| ChemicalBook | CB51176244 | |||
| Guide to Pharmacology | 11243 | |||
| rxnorm | DARUNAVIR | DARUNAVIR ETHANOLATE | PREZISTA | |
| PubChem: Drugs of the Future | 12015589 | |||
| ChEBI | 367163 | |||
| ZINC | ZINC000003955219 |
